Globus Medical, Inc. (GMED) Free Cash Flow
Globus Medical, Inc. (GMED) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | $74.05M |
| 2017-12-31 | $106.52M |
| 2018-12-31 | $126.95M |
| 2019-12-31 | $101.22M |
| 2020-12-31 | $135.13M |
| 2021-12-31 | $219.38M |
| 2022-12-31 | $104.42M |
| 2023-12-31 | $165.22M |
| 2024-12-31 | $405.21M |
| 2025-12-31 | $579.02M |
How GMED compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| BMRN | BioMarin Pharmaceutical Inc. | $717.02M |
| HSIC | Henry Schein Inc. | $573.00M |
| ENSG | The Ensign Group Inc. | $564.27M |
| ALGN | Align Technology Inc. | $490.78M |
| ALNY | Alnylam Pharmaceuticals Inc. | $465.38M |
These are five companies in the same sector as GMED with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Globus Medical, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("GMED", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | GMED | $80.48 | -1.09% | 1.05M |
| 3 | ||||
| 4 | ||||
| 5 |